UK Value-Based Pricing Proposals Aim To Increase Access, Broaden Assessment of Drug Benefits
This article was originally published in The Pink Sheet Daily
Executive Summary
An outline of the proposed overhaul to U.K. drug pricing and evaluation post-2013 is out for consultation until March 2011.